Facilitated PCI with pharmacological treatment helps establish early reperfusion before catheterisation

Facilitation with abciximab is the only recommendation based on published positive studies

When dilating a saphenous vein graft, the use of distal protection devices or thrombectomy devices may help prevent post-procedural events, such as no reflow and cardiogenic shock

Considering the limited options available, PCI is a valid therapeutic strategy in these patients

Given the lack of conclusive supporting evidence, the consensus among experts is that “culprit only” intervention should be the recommended strategy. However, all accessible vessels should be treated in patients with shock

We recommend careful assessment of the risk of developing cardiogenic shock in each patient to ensure early diagnosis and to allow rapid transfer and adequate intervention

Glyceryl trinitrate, verapamil, papaverine, nitroprusside, and adenosine are not recommended at this time. Optimal treatment for no reflow remains undetermined

Elderly patients are generally good candidates for angioplasty (and less so for thrombolysis)

Early discharge (day 3) after optimal PCI for uncomplicated AMI in low risk patients is recommended.

Early discharge is not recommended in high risk patients or following any complication or unsatisfactory procedure.